Cognitive Behavioral Therapy for Melanoma

This trial aims to determine if cognitive behavioral therapy for cancer distress (CBT-C) can improve the quality of life for individuals with stage III-IV melanoma after treatment. It examines how patients feel and manage daily life, focusing on stress, sleep problems, and social life changes. Participants will either attend weekly CBT-C sessions or receive standard care for six weeks. Eligible participants should have been diagnosed with stage III-IV melanoma within the last two months and be able to read English. As an unphased trial, this study offers a unique opportunity to explore new methods for enhancing well-being and managing cancer-related challenges.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that cognitive behavioral therapy (CBT) is safe and well-tolerated for people experiencing cancer-related stress. Past studies have found that CBT significantly reduces distress and improves the quality of life for patients with melanoma. One study found that CBT lowered anxiety and depression, with benefits lasting at least six months. Another study showed that CBT could boost resilience, helping patients handle stress and emotional challenges better.

Researchers are excited about using Cognitive Behavioral Therapy (CBT) for melanoma patients because it offers a unique way to address mental health challenges alongside physical treatment. Unlike traditional care that focuses primarily on the physical aspects of melanoma, CBT targets the emotional and psychological well-being of patients, helping them cope with the stress and anxiety that can accompany a cancer diagnosis. This approach is especially noteworthy because it could enhance patients' overall quality of life, potentially leading to better treatment outcomes. By integrating mental health support with cancer care, CBT aims to provide a more holistic treatment experience for patients.

Research has shown that cognitive behavioral therapy (CBT) can greatly help cancer patients manage stress and improve their quality of life. In this trial, some participants will attend CBT sessions once a week for six weeks. One study found that CBT reduced stress and improved the well-being of melanoma patients experiencing moderate to high levels of distress. Another study found that CBT significantly improved depression in cancer survivors, even months after the therapy ended. Evidence suggests that CBT is one of the most effective psychological treatments for enhancing overall quality of life and reducing fatigue from cancer treatments. These findings indicate that CBT could greatly benefit people facing the stress and challenges of melanoma.¹²⁴⁶⁷